Schedule III-V prescription past five total fills. Drug Enforcement. pharmacies that were shipping tramadol prescriptions into North Dakota. Investigations showed these pharmacies were filling prescriptions that did not have a valid patient-practitioner relation-ship. The pharmacies were also cited for a failure to report the prescriptions for tramadol to the Prescription Drug Monitoring. Currently, 10 states classify tramadol as Schedule IV under state law, with requirements that meet or exceed federal standards. They are Arkansas, Illinois, Kentucky, Mississippi, New Mexico, New York, Oklahoma, Tennessee, North Dakota and Wyoming, the DEA said. Prescription Drug Monitoring Program Program Description. The 2005 North Dakota Legislative Assembly authorized the implementation of a Prescription Drug Monitoring Program (PDMP), in the North Dakota Century Code chapter 19-03.5 and rules of the Board of Pharmacy. *Program may be recently established and/or may not yet be collecting data. A tramadol tapering schedule gives the person a hands-off role in the planning process so they can concentrate on the recovery itself. Physicians will craft a schedule on a patient-by-patient basis, but these will most certainly include check-ins and appointments while in a healthcare facility. Yes, tramadol is clasified by the US DEA as a schedule IV controlled substance. There is an ongoing concern that tramadol (Ultram, Ultram ER, Ultracet, ConZip, Ryzolt, Rybix ODT), a narcotic-like pain reliever, is linked with drug abuse, addiction, and overdose. News North Dakota State Board of Pharmacy December 2014 ND ol 4 No 1 Page 1 New Rule on the Use of the PDMP in Certain Circumstances Effective as of October 1, 2014 The North Dakota State Board of Pharmacy took comments and made modifications during the North Dakota Pharmacists As-sociation Annual Convention in Fargo, ND, on the rule requiring use of the North Dakota Prescription Drug. Scheduling of Tramadol North Dakota House Bill 1070 passed the North Dakota House and Senate and was signed by Governor Jack Dalrymple. This billincluded revisions to Schedule I through V controlled substances Schedule 4 (IV) Drugs. The drug has a low potential for abuse relative to the drugs in schedule 3 The drug has a currently accepted medical use in treatment in the United States. The Board of Pharmacy protects, preserves and promotes the public health and welfare of the citizens of North Dakota by assuring that the highest quality pharmaceutical care is delivered and that appropriate use of pharmaceuticals is upheld through education, communication, licensing, legislation, regulation, and enforcement.